APA
Lamb D. J., Wollin S. L., Schnapp A., Bischoff D., Erb K. J., Bouyssou T., Guilliard B., Strasser C., Wex E., Blum S., Thaler E., Nickel H., Radmacher O., Haas H., Swantek J. L., Souza D., Canfield M., White D., Panzenbeck M., Kashem M. A., Sanville-Ross M., Kono T., Sewald K., Braun A., Obernolte H., Danov O., Schaenzle G., Rast G., Maier G. & Hoffmann M. (20170523). BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells. : The Journal of pharmacology and experimental therapeutics.
Chicago
Lamb David J, Wollin Stefan Lutz, Schnapp Andreas, Bischoff Daniel, Erb Klaus J, Bouyssou Thierry, Guilliard Bernd, Strasser Christine, Wex Eva, Blum Sylvia, Thaler Eva, Nickel Helga, Radmacher Oliver, Haas Hannah, Swantek Jennifer L, Souza Don, Canfield Melissa, White Della, Panzenbeck Mark, Kashem Mohammed A, Sanville-Ross Mary, Kono Takeshi, Sewald Katherina, Braun Armin, Obernolte Helena, Danov Olga, Schaenzle Gerhard, Rast Georg, Maier Gerd-Michael and Hoffmann Matthias. 20170523. BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells. : The Journal of pharmacology and experimental therapeutics.
Harvard
Lamb D. J., Wollin S. L., Schnapp A., Bischoff D., Erb K. J., Bouyssou T., Guilliard B., Strasser C., Wex E., Blum S., Thaler E., Nickel H., Radmacher O., Haas H., Swantek J. L., Souza D., Canfield M., White D., Panzenbeck M., Kashem M. A., Sanville-Ross M., Kono T., Sewald K., Braun A., Obernolte H., Danov O., Schaenzle G., Rast G., Maier G. and Hoffmann M. (20170523). BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells. : The Journal of pharmacology and experimental therapeutics.
MLA
Lamb David J, Wollin Stefan Lutz, Schnapp Andreas, Bischoff Daniel, Erb Klaus J, Bouyssou Thierry, Guilliard Bernd, Strasser Christine, Wex Eva, Blum Sylvia, Thaler Eva, Nickel Helga, Radmacher Oliver, Haas Hannah, Swantek Jennifer L, Souza Don, Canfield Melissa, White Della, Panzenbeck Mark, Kashem Mohammed A, Sanville-Ross Mary, Kono Takeshi, Sewald Katherina, Braun Armin, Obernolte Helena, Danov Olga, Schaenzle Gerhard, Rast Georg, Maier Gerd-Michael and Hoffmann Matthias. BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells. : The Journal of pharmacology and experimental therapeutics. 20170523.